CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- 4 Planned sale See Remarks sold 21,156 shares at $8.20 ($173,479)
- 4 Planned sale Chief Development Officer sold 2,967 shares at $8.20 ($24,329)
- 4 Planned sale Chief Scientific Officer sold 3,018 shares at $8.20 ($24,748)
- 4 Planned sale Chief Strategy Officer sold 1,858 shares at $8.20 ($15,236)
- 4 Gift See Remarks gave 394,696 shares (gift)
- 4 Planned sale See Remarks sold 20,056 shares at $8.28 ($166,064)
- 4 Planned sale Chief Development Officer sold 2,810 shares at $8.28 ($23,267)
- 4 Planned sale Chief Scientific Officer sold 3,057 shares at $8.28 ($25,312)
- 4 Planned sale Chief Strategy Officer sold 1,759 shares at $8.28 ($14,565)
- 4 Planned sale Chief Medical Officer sold 3,510 shares at $7.74 ($27,167)
- 4 Open-market buy Director bought 60,229 shares at $7.66 ($461,354)
- 4 Open-market sale Chief Operating Officer sold 11,446 shares at $9.04 ($103,472)
- 4 Planned sale Chief Strategy Officer sold 10,348 shares at $9.04 ($93,546)
- 4 Planned sale See Remarks sold 124,882 shares at $9.04 ($1,128,933)
- 4 Planned sale Chief Medical Officer sold 7,863 shares at $9.04 ($71,082)
- 4 Open-market sale Chief Operating Officer sold 11,490 shares at an average $8.82 ($101,398)
- 4 Grant or award Global CCO acquired 136,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 2 of 18 · 354 filings